LNC
NUVB icon

Lincoln National Corp’s Nuvation Bio NUVB Stock Holding History

Lincoln National Corp’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,000
Closed -$105K – 869
2021
Q1 		$105K Hold
10,000
– – ﹤0.01% 784
2020
Q4 		$117K Buy
+10,000
New +$104K ﹤0.01% 726

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Lincoln National Corp's NUVB Position: Q2 2021 in Review

Lincoln National Corp sold out of Nuvation Bio (NUVB) in Q2 2021, closing a stake of 10,000 shares — an estimated $105K sold.

Lincoln National Corp first reported a position in NUVB in Q4 2020 and held it in 2 quarters. The position peaked at $117K in Q4 2020. 99 funds tracked by Wall St. Rank hold NUVB as of Q2 2021.

  • Lincoln National Corp reported no remaining Nuvation Bio position as of Q2 2021 after selling out during the quarter.
  • Lincoln National Corp sold 10,000 Nuvation Bio shares in Q2 2021, an estimated $105K.
  • Lincoln National Corp first reported a position in Nuvation Bio in Q4 2020 and held it in 2 quarters.
  • Lincoln National Corp's Nuvation Bio position peaked at $117K in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2021.

Based on Lincoln National Corp's 13F filing for Q2 2021, filed 13 Aug 2021.